Acquisition by Robert Weingarten of 200000 shares of Lixte Biotechnology subject to Rule 16b-3
GHSIDelisted Stock | USD 3.29 0.04 1.23% |
Under 52% of Guardion Health's investor base is interested to short. The analysis of overall sentiment of trading Guardion Health Sciences pink sheet suggests that many investors are impartial at this time. Guardion Health's investing sentiment shows overall attitude of investors towards Guardion Health Sciences.
Guardion |
Filed transaction by Lixte Biotechnology Holdings Officer Vice President And Cfo. Grant, award or other acquisition pursuant to Rule 16b-3
Read at macroaxis.com
Guardion Health Fundamental Analysis
We analyze Guardion Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Guardion Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Guardion Health based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Earnings Per Share
Earnings Per Share Comparative Analysis
Guardion Health is currently under evaluation in earnings per share category among its peers. Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.
Guardion Health Sciences Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Guardion Health pink sheet to make a market-neutral strategy. Peer analysis of Guardion Health could also be used in its relative valuation, which is a method of valuing Guardion Health by comparing valuation metrics with similar companies.
Peers
Guardion Health Related Equities
IMCC | Im Cannabis | 8.13 | ||||
CPHI | China Pharma | 5.26 | ||||
UPC | Universe Pharmaceuticals | 3.49 | ||||
AKAN | Akanda Corp | 2.94 | ||||
TKNO | Alpha Teknova | 1.63 | ||||
EVOK | Evoke Pharma | 1.37 | ||||
RAPH | Raphael Pharmaceutical | 0.00 | ||||
ORGO | Organogenesis Holdings | 0.77 | ||||
LFCR | Lifecore Biomedical | 1.20 | ||||
AQST | Aquestive Therapeutics | 1.36 | ||||
SHPH | Shuttle Pharmaceuticals | 2.30 | ||||
PTPI | Petros Pharmaceuticals | 6.90 | ||||
BFRI | Biofrontera | 9.09 | ||||
CYTH | Cyclo Therapeutics | 11.11 |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Other Consideration for investing in Guardion Pink Sheet
If you are still planning to invest in Guardion Health Sciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Guardion Health's history and understand the potential risks before investing.
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume |